glp 1 receptor agonists examples Trends in the Development of GLP-1 Evolution of GLP‐1 Receptor Agonists

National Taiwan University researchers highlight the benefits of GLP-1 receptor agonists (GLP-1 RAs) in reducing mortality and severe cardiovascular and renal outcomes for diabetic patients with acute kidney disease (AKD)

It has been studied in human clinical trials and shown to support metabolic balance, healthy blood glucose regulation, inflammation management, and improved insulin function

Designed in an easy-to-use tablet format, this product provides a convenient alternative to injectable GLP-1 options

SGLT-2 inhibitors are superior to GLP-1RA in reducing the risk of HHF and renal events

GLP-1 is also secreted by -cells of the pancreas and the central nervous system (CNS)

Otolaryngologist patients with medullary thyroid cancer should not be taking GLP-1 medications at this time due to the risk.